SKI Market

A+| A| A-|

Indian Indices

Sensex

76,802.90 -607.08
( -0.78%)

Global Indices

Nasdaq

51,585.70 72.15
(0.14%)

Dow Jones

7,521.58 80.48
(1.08%)

Hang Seng

70,971.12 -82.37
(-0.12%)

Nikkei 225

10,357.71 -41.99
(-0.40%)

Forex

USD-INR

94.39 -0.12
(-0.13%)

EUR-INR

108.40 -1.03
(-0.94%)

GBP-INR

125.08 -1.43
(-1.13%)

JPY-INR

0.59 0.00
(-0.50%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Torrent Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

500420

INE685A01028

249.7348678

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

TORNTPHARM

67.72

149819.64

EPS(TTM)

Face Value()

Div & Yield %

65.37

0.86

Back

Jindal Worldwide consolidated net profit declines 22.33% in the December 2025 quarter

Feb 13,2026

Net profit of Jindal Worldwide declined 22.33% to Rs 14.33 crore in the quarter ended December 2025 as against Rs 18.45 crore during the previous quarter ended December 2024. Sales declined 14.77% to Rs 532.12 crore in the quarter ended December 2025 as against Rs 624.30 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	532.12	624.30	-15
OPM %	4.18	8.12	-
PBDT	22.10	34.41	-36
PBT	18.25	25.08	-27
NP	14.33	18.45	-22

76,802.90 -607.08 ( -0.78%)

51,585.70 72.15 (0.14%)

7,521.58 80.48 (1.08%)

70,971.12 -82.37 (-0.12%)

10,357.71 -41.99 (-0.40%)

94.39 -0.12 (-0.13%)

108.40 -1.03 (-0.94%)

125.08 -1.43 (-1.13%)

0.59 0.00 (-0.50%)